Prostate specific acid phosphatase: further studies with immunological techniques
In the continuing saga of examining new immunological methods for the measurement of prostate-specific acid phosphatase (PAcP), we have compared the new technique of immunoenzymatic assay (IEA) to radioimmunoassay (RIA). No marked advantages in either the early diagnosis or the follow-up of prostati...
Gespeichert in:
Veröffentlicht in: | Clinica chimica acta 1982-06, Vol.122 (1), p.29-38 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 38 |
---|---|
container_issue | 1 |
container_start_page | 29 |
container_title | Clinica chimica acta |
container_volume | 122 |
creator | Davies, Sally N. Griffiths, John C. |
description | In the continuing saga of examining new immunological methods for the measurement of prostate-specific acid phosphatase (PAcP), we have compared the new technique of immunoenzymatic assay (IEA) to radioimmunoassay (RIA). No marked advantages in either the early diagnosis or the follow-up of prostatic cancer were apparent, with comparable specificities and sensitivities for both methods. The simple procedure, inexpensive equipment and stable reagents needed for the IEA were its major advantages. A comparison with digital rectal examination suggests that until the 'at risk' population is screened regularly by a PAcP assay, the most appropriate use of the assay is monitoring treatment effectivity. |
doi_str_mv | 10.1016/0009-8981(82)90091-2 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74105079</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0009898182900912</els_id><sourcerecordid>74105079</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-9c988a855a6d8500c0d6addc5118a048137af6fb3e5e73efd01750126e87cdca3</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMo67r6DRRyEj1Uk6ZpUg-CLP6DBRX0HLLJ1EbabU1SxW9v6y579DQ85r0Z3g-hY0ouKKH5JSGkSGQh6ZlMz4tB0CTdQVMqBUtYVqS7aLq17KODED4GmZGcTtAkp0JyJqfo5dm3IeoIOHRgXOkM1sZZ3FVt6CoddYArXPY-VuBxiL11EPC3ixV2TdOv2rp9d0bXOIKpVu6zh3CI9kpdBzjazBl6u7t9nT8ki6f7x_nNIjGMi5gUppBSS851biUnxBCba2sNp1RqkknKhC7zcsmAg2BQWkIFJzTNQQpjjWYzdLq-2_l2_BtV44KButYraPugREYJJ6IYjNnaaIaqwUOpOu8a7X8UJWokqUZMasSkZKr-SKp0iJ1s7vfLBuw2tEE37K_XexhKfjnwKhgHKwPWeTBR2db9_-AXUqKDxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74105079</pqid></control><display><type>article</type><title>Prostate specific acid phosphatase: further studies with immunological techniques</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Davies, Sally N. ; Griffiths, John C.</creator><creatorcontrib>Davies, Sally N. ; Griffiths, John C.</creatorcontrib><description>In the continuing saga of examining new immunological methods for the measurement of prostate-specific acid phosphatase (PAcP), we have compared the new technique of immunoenzymatic assay (IEA) to radioimmunoassay (RIA). No marked advantages in either the early diagnosis or the follow-up of prostatic cancer were apparent, with comparable specificities and sensitivities for both methods. The simple procedure, inexpensive equipment and stable reagents needed for the IEA were its major advantages. A comparison with digital rectal examination suggests that until the 'at risk' population is screened regularly by a PAcP assay, the most appropriate use of the assay is monitoring treatment effectivity.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/0009-8981(82)90091-2</identifier><identifier>PMID: 6178538</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acid Phosphatase - analysis ; Adenocarcinoma - enzymology ; Adult ; Aged ; False Positive Reactions ; Female ; Humans ; Immunoenzyme Techniques ; Male ; Middle Aged ; Prostate - enzymology ; Prostatectomy ; Prostatic Hyperplasia - enzymology ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - enzymology ; Radioimmunoassay</subject><ispartof>Clinica chimica acta, 1982-06, Vol.122 (1), p.29-38</ispartof><rights>1982</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-9c988a855a6d8500c0d6addc5118a048137af6fb3e5e73efd01750126e87cdca3</citedby><cites>FETCH-LOGICAL-c357t-9c988a855a6d8500c0d6addc5118a048137af6fb3e5e73efd01750126e87cdca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0009-8981(82)90091-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6178538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davies, Sally N.</creatorcontrib><creatorcontrib>Griffiths, John C.</creatorcontrib><title>Prostate specific acid phosphatase: further studies with immunological techniques</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>In the continuing saga of examining new immunological methods for the measurement of prostate-specific acid phosphatase (PAcP), we have compared the new technique of immunoenzymatic assay (IEA) to radioimmunoassay (RIA). No marked advantages in either the early diagnosis or the follow-up of prostatic cancer were apparent, with comparable specificities and sensitivities for both methods. The simple procedure, inexpensive equipment and stable reagents needed for the IEA were its major advantages. A comparison with digital rectal examination suggests that until the 'at risk' population is screened regularly by a PAcP assay, the most appropriate use of the assay is monitoring treatment effectivity.</description><subject>Acid Phosphatase - analysis</subject><subject>Adenocarcinoma - enzymology</subject><subject>Adult</subject><subject>Aged</subject><subject>False Positive Reactions</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostate - enzymology</subject><subject>Prostatectomy</subject><subject>Prostatic Hyperplasia - enzymology</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - enzymology</subject><subject>Radioimmunoassay</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LxDAQxYMo67r6DRRyEj1Uk6ZpUg-CLP6DBRX0HLLJ1EbabU1SxW9v6y579DQ85r0Z3g-hY0ouKKH5JSGkSGQh6ZlMz4tB0CTdQVMqBUtYVqS7aLq17KODED4GmZGcTtAkp0JyJqfo5dm3IeoIOHRgXOkM1sZZ3FVt6CoddYArXPY-VuBxiL11EPC3ixV2TdOv2rp9d0bXOIKpVu6zh3CI9kpdBzjazBl6u7t9nT8ki6f7x_nNIjGMi5gUppBSS851biUnxBCba2sNp1RqkknKhC7zcsmAg2BQWkIFJzTNQQpjjWYzdLq-2_l2_BtV44KButYraPugREYJJ6IYjNnaaIaqwUOpOu8a7X8UJWokqUZMasSkZKr-SKp0iJ1s7vfLBuw2tEE37K_XexhKfjnwKhgHKwPWeTBR2db9_-AXUqKDxQ</recordid><startdate>19820616</startdate><enddate>19820616</enddate><creator>Davies, Sally N.</creator><creator>Griffiths, John C.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19820616</creationdate><title>Prostate specific acid phosphatase: further studies with immunological techniques</title><author>Davies, Sally N. ; Griffiths, John C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-9c988a855a6d8500c0d6addc5118a048137af6fb3e5e73efd01750126e87cdca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Acid Phosphatase - analysis</topic><topic>Adenocarcinoma - enzymology</topic><topic>Adult</topic><topic>Aged</topic><topic>False Positive Reactions</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostate - enzymology</topic><topic>Prostatectomy</topic><topic>Prostatic Hyperplasia - enzymology</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - enzymology</topic><topic>Radioimmunoassay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davies, Sally N.</creatorcontrib><creatorcontrib>Griffiths, John C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davies, Sally N.</au><au>Griffiths, John C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostate specific acid phosphatase: further studies with immunological techniques</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>1982-06-16</date><risdate>1982</risdate><volume>122</volume><issue>1</issue><spage>29</spage><epage>38</epage><pages>29-38</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>In the continuing saga of examining new immunological methods for the measurement of prostate-specific acid phosphatase (PAcP), we have compared the new technique of immunoenzymatic assay (IEA) to radioimmunoassay (RIA). No marked advantages in either the early diagnosis or the follow-up of prostatic cancer were apparent, with comparable specificities and sensitivities for both methods. The simple procedure, inexpensive equipment and stable reagents needed for the IEA were its major advantages. A comparison with digital rectal examination suggests that until the 'at risk' population is screened regularly by a PAcP assay, the most appropriate use of the assay is monitoring treatment effectivity.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>6178538</pmid><doi>10.1016/0009-8981(82)90091-2</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-8981 |
ispartof | Clinica chimica acta, 1982-06, Vol.122 (1), p.29-38 |
issn | 0009-8981 1873-3492 |
language | eng |
recordid | cdi_proquest_miscellaneous_74105079 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Acid Phosphatase - analysis Adenocarcinoma - enzymology Adult Aged False Positive Reactions Female Humans Immunoenzyme Techniques Male Middle Aged Prostate - enzymology Prostatectomy Prostatic Hyperplasia - enzymology Prostatic Neoplasms - diagnosis Prostatic Neoplasms - drug therapy Prostatic Neoplasms - enzymology Radioimmunoassay |
title | Prostate specific acid phosphatase: further studies with immunological techniques |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A32%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostate%20specific%20acid%20phosphatase:%20further%20studies%20with%20immunological%20techniques&rft.jtitle=Clinica%20chimica%20acta&rft.au=Davies,%20Sally%20N.&rft.date=1982-06-16&rft.volume=122&rft.issue=1&rft.spage=29&rft.epage=38&rft.pages=29-38&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/0009-8981(82)90091-2&rft_dat=%3Cproquest_cross%3E74105079%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74105079&rft_id=info:pmid/6178538&rft_els_id=0009898182900912&rfr_iscdi=true |